Authors: Peltola, J Ukkonen, M Moilanen, E Elovaara, I

Citation: J. Peltola et al., Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy, NEUROLOGY, 57(5), 2001, pp. 895-896

Authors: Luomala, M Elovaara, I Ukkonen, M Koivula, T Lehtimaki, T

Citation: M. Luomala et al., The combination of HLA-DR1 and HLA-DR53 protects against MS, NEUROLOGY, 56(3), 2001, pp. 383-385

Authors: Luomala, M Lehtimaki, T Elovaara, I Wang, XY Ukkonen, M Mattila, K Laippala, P Koivula, T Hurme, M

Citation: M. Luomala et al., A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis, J NEUR SCI, 185(2), 2001, pp. 123-127

Authors: Luomala, M Elovaara, I Ukkonen, M Koivula, T Lehtimaki, T

Citation: M. Luomala et al., Plasminogen activator inhibitor 1 gene and risk of MS in women, NEUROLOGY, 54(9), 2000, pp. 1862-1864

Authors: Elovaara, I Ukkonen, M Leppakynnas, M Lehtimaki, T Luomala, M Peltola, J Dastidar, P

Citation: I. Elovaara et al., Adhesion molecules in multiple sclerosis - Relation to subtypes of diseasemethylprednisolone therapy, ARCH NEUROL, 57(4), 2000, pp. 546-551

Authors: Dastidar, P Heinonen, T Lehtimaki, T Ukkonen, M Peltola, J Erila, T Laasonen, E Elovaara, I

Citation: P. Dastidar et al., Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis, J NEUR SCI, 165(1), 1999, pp. 36-42